Clinical Trial Update: Dose Ranging Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate [Phase 2]

View source ↗

Summary

A Phase 2 dose-ranging study evaluating ART621 in rheumatoid arthritis patients taking methotrexate has been terminated; no efficacy results are provided in thi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ART621

Snippet

Sponsor: Arana Therapeutics Ltd | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED